JOURNAL ARTICLE

A phase II study of α-interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia

Keywords:
Medicine Myeloid leukemia Internal medicine Gastroenterology Adverse effect Phases of clinical research Toxicity

Metrics

12
Cited By
0.57
FWCI (Field Weighted Citation Impact)
31
Refs
0.62
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Chronic Myeloid Leukemia Treatments
Health Sciences →  Medicine →  Hematology
Eosinophilic Disorders and Syndromes
Health Sciences →  Medicine →  Rheumatology
Acute Lymphoblastic Leukemia research
Health Sciences →  Medicine →  Public Health, Environmental and Occupational Health
© 2026 ScienceGate Book Chapters — All rights reserved.